Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst ’s FDA approval and implications

Volume 15, Issue 1, January-December 2023 .
Source: Gut Microbes - Category: Microbiology Authors: Source Type: research
More News: Microbiology